Randi graduated from Binghamton University with a B.A. in Psychology and J.D. from Hofstra University Law School. Before joining Sanders Phillips Grossman, LLC., Randi Kassan, specialized in mass claim insurance litigation for three years at Baker Sanders, LLC.. She now specializes in Litigation involving pharmaceutical and devices making Partner at Sanders Phillips Grossman, LLC in 2011. Randi was initially admitted to practice in Federal and State Courts in New York. Further in her career, she was admitted to numerous other state and federal courts to help pursue her client’s interests across the country.
Randi’s mass tort experience stems from the early years of pharmaceutical litigation specializing in the Vioxx litigation working on discovery including third party research and subpoenas; the Avandia steering committee, as well as running the discovery committee during the firm’s Fosamax trial in the Superior Court of New Jersey. Randi continued to do voluminous work for Steering Committees regarding document review, witness research, jury selection, and the bellwether trial process.
Randi has garnered a plethora of experience and knowledge in the mass tort community by staying intimately involved in all facets of the litigations, specifically Electronic Storage discovery, Party and Non-Party Discovery and Science in multiple mass torts across the country. She is a member of the Steering Committee in Zimmer NexGen Knee Multi-District litigation in Illinois where she led the negotiations for developing the Case Management Order for Electronic Storage Information (ESI). She also led the negotiations for the Electronic Discovery protocol for the Propecia Multi-District Litigation (MDL) in the Eastern District of New York. Randi was appointed as a steering committee member in the In Re: Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation in the District of Massachusetts as well as the Mirena litigation in the Southern District of New York. She was a contributing member of the ESI and discovery committees in the Benicar MDL in New Jersey and Mirena Litigation in New York and New Jersey.
She participated in speaking engagements for Harris Martin on the Medtronic bone infuse and Fresenius litigation as well as many topics at Mass Tort Med School.
Randi is the litigation and operations manager, managing over 15 litigations including intake, review of cases, client communication, filing of complaints, written discovery, motion practice, expert reports, court conferences, bellwether trial workup, settlement negotiations and settlement process.
Ms. Kassan has previously worked on the following litigation matters including Bextra/Celebrex, Oxycontin II, Byetta/Januvia, Actos, Granuflo, Reglan, Guidant defibrillator litigation, Stryker Hips, Biomet Hips, Depuy Hips, certain parts of the Zimmer NexGen Knee, Invokana, Fluoroquinolone, Zicam Cold and Remedy, Mirena, Crestor, Bone Infuse, and Chantix in Alabama and New York.
Randi is currently concentrating on representing women with injuries from Taxotere, Transvaginal Mesh, and Talcum Powder. Additionally Randi is working on representing unions and municipalities in the Opiate litigation pending in New York, Illinois and Ohio.
Randi is a member of the American Association of Justice, New York Bar Association and National Trial Lawyers. She is admitted to practice law in the States of New York, Missouri, Massachusetts, Minnesota, Pennsylvania, and Washington DC. She is admitted to practice in numerous federal courts across the country including the United States District Courts in the Eastern, Western, Northern and Southern Districts of New York, Massachusetts, Pennsylvania, Illinois and the District of Colorado.